Jacobi Capital Management LLC Novo Cure LTD Transaction History

Jacobi Capital Management LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$116.17 - $194.55 $10,687 - $17,898	-92 Closed	0 $0
Q2 2021 Aug 12, 2021	BUY	$130.4 - $225.58 $1,304 - $2,255	10 Added 12.2%	92 $20,000
Q1 2021 May 11, 2021	BUY	$124.11 - $190.17 $7,074 - $10,839	57 Added 228.0%	82 $11,000
Q4 2020 Feb 08, 2021	BUY	$112.16 - $174.14 $112 - $174	1 Added 4.17%	25 $4,000
Q3 2020 Oct 30, 2020	BUY	$58.05 - $111.31 $696 - $1,335	12 Added 100.0%	24 $3,000
Q2 2020 Aug 04, 2020	SELL	$57.2 - $74.41 $18,189 - $23,662	-318 Reduced 96.36%	12 $1,000
Q2 2020 Jul 27, 2020	BUY	$57.2 - $74.41 $18,876 - $24,555	330 New	330 $1,000

262

77M

1.17M

318K

Ticker NVCR
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 104,950,000
Market Cap $1.86B
Description
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...

Get notified when there are updates to the investment portfolio of Jacobi Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Jacobi Capital Management LLC with notifications on news.